DVA:NYSE
Davita Inc
179,25 USD
arrow_upward
+1,26%(+2,23) 1D
179,25 USD
0,00% (0,00)
bedtimeNakon radnog vremena
Zatvoreno: 9. lis, 16:00:03 GMT -4 · USD
search
Svi simboli
| Simbol | Cijena | Promjena | Postotna promjena |
|---|
insights_autoGeneriranje najvažnijih uvida za DVA...
Otvori
177,00 USD
Najviša
180,11 USD
Najniža
177,00 USD
Trž. kap.
11,44 mlr.
Prosj. kol.
659,00 tis.
Količina
369,64 tis.
P/E omjer
14,68
52-tjed. najviša
247,49 USD
52-tjed. najniža
101,00 USD
EPS
12,21 USD
Beta
0,80
Dionice u optjecaju
63,80 mil.
Broj djelatnika
78 tis.
Otvori
177,00 USD
Najviša
180,11 USD
Najniža
177,00 USD
Trž. kap.
11,44 mlr.
Prosj. kol.
659,00 tis.
Količina
369,64 tis.
P/E omjer
14,68
52-tjed. najviša
247,49 USD
52-tjed. najniža
101,00 USD
EPS
12,21 USD
Beta
0,80
Dionice u optjecaju
63,80 mil.
Broj djelatnika
78 tis.
Vijesti
Iz web-izvora i od partnera za vijesti
Zacks
·
prije 1 dan
Why DaVita HealthCare (DVA) Outpaced the Stock Market Today
News Corp
·
prije 1 dan
DaVita Inc. stock underperforms Friday when compared to competitors despite daily gains
Seeking Alpha
·
prije 1 dan
DaVita: After A 25% Drop, The Buyback Machine Is Cheap Again (NYSE:DVA)
Zacks
·
prije 2 dana
Here's Why You Should Retain DaVita Stock in Your Portfolio for Now
Profil
DaVita Inc. is an American health care company, incorporated in Delaware and headquartered in Denver, that provides kidney dialysis services through a network of 2,657 outpatient centers in the United States. DaVita serves 200,500 patients, and has 585 outpatient centers in 14 other countries serving 94,500 patients. The company primarily treats end-stage renal disease, which requires patients to undergo kidney dialysis, often 3 times per week for the rest of their lives unless they receive a kidney transplant via organ donation.
In 2025, 68% of the company's revenues came from Medicare and other government-based health insurance programs. In 2025, 89% of the company's patients were covered by government-based health insurance programs. Commercial payers, which accounted for 32% of revenues in 2025, generate nearly all of the company's profit as they reimburse at a much higher rate than government-based health insurance programs. The company is ranked 331st on the 2026 Fortune 500. Wikipedia
Davita Inc – informacije
Glavni izvršni direktorJavier J. Rodriguez
Zaposlenici78 tis.
Osnovano1992
SjedišteDenver, Colorado, Sjedinjene Američke Države
SektorHealth care provider
Web-lokacijadavita.com